Treatment of decompensated HCV cirrhosis in patients with diverse genotypes:
12 weeks sofosbuvir and NS5A inhibitors with/without ribavirin is effective in HCV Genotypes 1 and 3
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
GR Foster, J. McLauchlan, W. Irving,
M. Cheung, B. Hudson, S. Verma, K. Agarwal, HCV Research UK EAP Group
